Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 662 pembrolizumab 612 Magnetic Resonance Spectroscopy 565 Carboplatin 451 Cisplatin 400 Cyclophosphamide 399 Biopsy 385 Nivolumab 329 Paclitaxel 324 Gemcitabine 317 Radiotherapy 302 Bevacizumab 250 Dexamethasone 223 fludarabine 217 Docetaxel 203 durvalumab 196 Oxaliplatin 189 venetoclax 188 atezolizumab 188 Fluorouracil 178 Rituximab 177 Pemetrexed 174 Capecitabine 172 Radiation 171 Doxorubicin 168 Radiosurgery 161 Ipilimumab 149 Etoposide 142 Leucovorin 141 Lenalidomide 140

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Escitalopram × 90 days × Clear all

NCT03728673 2026-04-17

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡